Netflix shocked Wall Street and "Mad Money" host Jim Cramer has his review.
Mad Money host Jim Cramer focuses on what the CBOE Volatility Index, or the VIX, is signaling to investors.
Mad Money host Jim Cramer is a big fan of Box, which is coming public later this week.
The news backdrop has become deeply gloomy, explains Mad Money host Jim Cramer.
Looking for opportunity in energy? Mad Money host Jim Cramer may have finally found the spot.
The future of transportation and biotech, featuring Klaus Kleinfeld, of Alcoa; Mike McNamara, Flextronics International; ron Cohen, Acorda Therapeutics; Dr. Francois Nader, NPS Pharmaceuticals; Dr. Helen Torley, Halozyme Therapeutics; Tim Mayleben, Esperion Therapeutics; Stanley Erck, Novavax; John Orwin, Relypsa; Faheem Hasnain, Receptos; Shane Kovacs, PTC Therapeutics; and JJ Bienaime, Biomarin Pharmaceutical.
Mad Money host Jim Cramer shares his thoughts of on Bill Johnson, former CEO of Heinz, joining the board of PepsiCo.
Happy medium? Mad Money's Jim Cramer says it's where oil stops going down for a while and lets the market catch its breath.
Mad Money host Jim Cramer looks ahead to next week's earnings, events, and data that will impact the market.
Mad Money host Jim Cramer shares his opinion on the big time retailer after its announced moved away from Canada.
JJ Bienaime, BioMarin Pharmaceuticals CEO, discusses the launch of Vimizim and the company's prospects, with Mad Money's Jim Cramer.
Mad Money's Jim Cramer says Target's Canadian expansion was one of the most monumental wipeouts of shareholder capital he has ever seen.
Amid global currency woes, Mad Money host Jim Cramer shares his view on why America is number 1.
Mad Money's Jim Cramer dissects the recent collapse in the commodities space. Cramer shares 3 trends investors should not underestimate.
Mad Money host Jim Cramer tries to make sense of current market action. Cramer says we are operating in a market where each day varies from the last.
Mad Money host Jim Cramer on the CEOs coaching their companies to new highs.
Mad Money host Jim Cramer goes off the charts with the help of Carly Garner of DeCarley Trading, who expects the long rally in bond prices to soon end.
Mad Money host Jim Cramer congratulates Disney's CEO Bob Iger and Celgene's CEO Bob Hugin for taking their stocks to all-time highs in Tuesday's market.
Mad Money host Jim Cramer shares his take on the strength, and then vicious selloff in Tuesday's trading session.
NPS Pharmaceuticals president and CEO Dr. Francois Nader discusses opportunities the potential deal with Shire presents.